Approval provided for Angelini’s cenobamate
Treatment will now be used across Ireland among adults with focal onset seizures with epilepsy
Read More
Tag: Angelini
EC approval for Ontozry
The drug offers new hope for epilepsy patients with focal-onset seizures
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
